CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 50 of 53 entries

View as:

Neuromuscular Electrical Stimulation for Children With Dysphagia

Phase: N/A Priority: Normal

NCT ID: NCT06309056 Org: User:

Start: 03/31/24 End: 03/31/26 Due: 03/31/27

Montreal Immune-Related Adverse Events (MIRAE) Study

Phase: N/A Priority: Normal

NCT ID: NCT05139706 Org: User:

Start: 01/21/20 End: 01/31/30 Due: 01/31/31

Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapy

Phase: N/A Priority: Normal

NCT ID: NCT03062254 Org: User:

Start: 03/22/18 End: 07/15/21 Due: 07/15/22

GRID Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors

Phase: N/A Priority: Normal

NCT ID: NCT02333110 Org: User:

Start: 01/31/15 End: 12/31/25 Due: 12/31/26

Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients

Phase: N/A Priority: Normal

NCT ID: NCT02303327 Org: User:

Start: 01/31/15 End: 01/31/29 Due: 01/31/30

Prostate Cancer Patient Management With 18F-DCFPyL PET/CT

Phase: N/A Priority: Normal

NCT ID: NCT03459820 Org: User:

Start: 06/22/18 End: 06/30/28 Due: 06/30/29

Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery

Phase: N/A Priority: Normal

NCT ID: NCT06530524 Org: User:

Start: 10/01/24 End: 12/01/27 Due: 12/01/28

The Safety of Transdermal Nicotine Immediately Following an Acute Coronary Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT00990197 Org: User:

Start: 06/30/05 End: 12/31/09 Due: 12/31/10

Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer

Phase: N/A Priority: Normal

NCT ID: NCT02793882 Org: User:

Start: 09/30/13 End: 04/24/17 Due: 04/24/18

Long-term Safety of Nipple Sparing Mastectomy in Women With GPV in Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT06888388 Org: User:

Start: 02/01/25 End: 02/01/28 Due: 02/01/29

Niraparib in High-grade Endometrial Cancer Trial

Phase: N/A Priority: Normal

NCT ID: NCT05289648 Org: User:

Start: 05/01/24 End: 01/31/26 Due: 01/31/27

Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial

Phase: N/A Priority: Normal

NCT ID: NCT01615705 Org: User:

Start: 06/30/04 End: 02/29/12 Due: 02/28/13

The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation Therapy

Phase: N/A Priority: Normal

NCT ID: NCT02573636 Org: User:

Start: 03/31/16 End: 03/31/27 Due: 03/31/28

Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline

Phase: N/A Priority: Normal

NCT ID: NCT03067402 Org: User:

Start: 03/20/17 End: 06/10/22 Due: 06/10/23

Nerve Grafting Technique to Restore Erectile Function Post Radical Prostatectomy

Phase: N/A Priority: Normal

NCT ID: NCT06458855 Org: User:

Start: 07/17/24 End: 09/30/27 Due: 09/30/28

Prospective Evaluation of Long-term Outcomes After Pulmonary Embolism

Phase: N/A Priority: Normal

NCT ID: NCT01174628 Org: User:

Start: 06/30/10 End: 02/28/15 Due: 02/28/16

No Surgery Trial / Two Dose-escalation Strategies

Phase: N/A Priority: Normal

NCT ID: NCT03051464 Org: User:

Start: 04/25/17 End: 01/31/30 Due: 01/31/31

The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient

Phase: N/A Priority: Normal

NCT ID: NCT02588404 Org: User:

Start: 12/31/15 End: 01/31/30 Due: 01/31/31

Increasing Physical Contact Between Prenatally Anxious/Depressed Mothers and Their Infants to Improve Maternal Sensitivity.

Phase: N/A Priority: Normal

NCT ID: NCT06726304 Org: User:

Start: 01/31/25 End: 05/31/26 Due: 05/31/27

68Ga-PSMA PET/CT in Prostate Cancer

Phase: N/A Priority: Normal

NCT ID: NCT03001869 Org: User:

Start: 07/01/17 End: 07/01/23 Due: 07/01/24

Hypotension Prediction Index in Postoperative Surgical Patients

Phase: N/A Priority: Normal

NCT ID: NCT05335174 Org: User:

Start: 04/01/22 End: 03/01/27 Due: 03/01/28

Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects

Phase: N/A Priority: Normal

NCT ID: NCT00388388 Org: User:

Start: 03/31/07 End: 12/31/09 Due: 12/31/10

Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

Phase: N/A Priority: Normal

NCT ID: NCT02220829 Org: User:

Start: 06/30/16 End: 08/31/23 Due: 08/31/24

The MUFFIN-PTS Trial

Phase: N/A Priority: Normal

NCT ID: NCT03833024 Org: User:

Start: 02/04/22 End: 05/30/24 Due: 05/30/25

A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer

Phase: N/A Priority: Normal

NCT ID: NCT01274962 Org: User:

Start: 11/30/09 End: 12/31/22 Due: 12/31/23

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Neuromuscular Electrical Stimulation for Children With Dysphagia	NCT06309056	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2024-03-31	2026-03-31	2027-03-31	-	-	2025-07-14
Montreal Immune-Related Adverse Events (MIRAE) Study	NCT05139706	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2020-01-21	2030-01-31	2031-01-31	-	-	2025-07-14
Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapy	NCT03062254	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2018-03-22	2021-07-15	2022-07-15	-	-	2025-07-14
GRID Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors	NCT02333110	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2015-01-31	2025-12-31	2026-12-31	-	-	2025-07-14
Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients	NCT02303327	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2015-01-31	2029-01-31	2030-01-31	-	-	2025-07-14
Prostate Cancer Patient Management With 18F-DCFPyL PET/CT	NCT03459820	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2018-06-22	2028-06-30	2029-06-30	-	-	2025-07-14
Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery	NCT06530524	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2024-10-01	2027-12-01	2028-12-01	-	-	2025-07-14
The Safety of Transdermal Nicotine Immediately Following an Acute Coronary Syndrome	NCT00990197	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2005-06-30	2009-12-31	2010-12-31	-	-	2025-07-14
Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer	NCT02793882	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2013-09-30	2017-04-24	2018-04-24	-	-	2025-07-14
Long-term Safety of Nipple Sparing Mastectomy in Women With GPV in Breast Cancer	NCT06888388	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2025-02-01	2028-02-01	2029-02-01	-	-	2025-07-14
Niraparib in High-grade Endometrial Cancer Trial	NCT05289648	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2024-05-01	2026-01-31	2027-01-31	-	-	2025-07-14
Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial	NCT01615705	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2004-06-30	2012-02-29	2013-02-28	-	-	2025-07-14
The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation Therapy	NCT02573636	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2016-03-31	2027-03-31	2028-03-31	-	-	2025-07-14
Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline	NCT03067402	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2017-03-20	2022-06-10	2023-06-10	-	-	2025-07-14
Nerve Grafting Technique to Restore Erectile Function Post Radical Prostatectomy	NCT06458855	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2024-07-17	2027-09-30	2028-09-30	-	-	2025-07-14
Prospective Evaluation of Long-term Outcomes After Pulmonary Embolism	NCT01174628	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2010-06-30	2015-02-28	2016-02-28	-	-	2025-07-14
No Surgery Trial / Two Dose-escalation Strategies	NCT03051464	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2017-04-25	2030-01-31	2031-01-31	-	-	2025-07-14
The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient	NCT02588404	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2015-12-31	2030-01-31	2031-01-31	-	-	2025-07-14
Increasing Physical Contact Between Prenatally Anxious/Depressed Mothers and Their Infants to Improve Maternal Sensitivity.	NCT06726304	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2025-01-31	2026-05-31	2027-05-31	-	-	2025-07-14
68Ga-PSMA PET/CT in Prostate Cancer	NCT03001869	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2017-07-01	2023-07-01	2024-07-01	-	-	2025-07-14
Hypotension Prediction Index in Postoperative Surgical Patients	NCT05335174	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2022-04-01	2027-03-01	2028-03-01	-	-	2025-07-14
Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects	NCT00388388	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2007-03-31	2009-12-31	2010-12-31	-	-	2025-07-14
Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy	NCT02220829	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2016-06-30	2023-08-31	2024-08-31	-	-	2025-07-14
The MUFFIN-PTS Trial	NCT03833024	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2022-02-04	2024-05-30	2025-05-30	-	-	2025-07-14
A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer	NCT01274962	Sir Mortimer B. Davis - Jewish General Hospital	user2@example.com	None	2009-11-30	2022-12-31	2023-12-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance